*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Blonanserin</strong> (CAS: 219045-67-3) is a novel atypical antipsychotic agent. Its core synthesis involves advanced heterocyclic coupling processes to achieve high purity standards for pharmaceutical intermediates. Molecular formula: <strong>C<sub>23</sub>H<sub>28</sub>F<sub>3</sub>N<sub>3</sub>O<sub>2</sub>.</strong></p>
<h3>Application</h3>
<ul>
<li>Treatment of schizophrenia in adult populations.</li>
<li>Management of positive and negative symptoms in psychiatric care.</li>
<li>Pharmaceutical manufacturing for generic tablet formulations.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly contraindicated for patients with severe hepatic impairment. Requires storage in cool, dry environments below 25°C under nitrogen protection to prevent degradation.</p>